American Shared Hospital Services (AMS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
The 2026 annual meeting will be held virtually on June 24, 2026, with shareholders voting on director elections, executive compensation, an amended incentive plan, and auditor ratification.
Shareholders of record as of April 27, 2026, are eligible to vote, with multiple voting methods available including online, phone, mail, and during the virtual meeting.
Proxy materials, including the annual report, are available electronically, and shareholders are encouraged to vote even if not attending.
Voting matters and shareholder proposals
Four directors are nominated for election: Daniel G. Kelly, Jr., Kathleen Miles, Raymond C. Stachowiak, and Vicki L. Wilson.
Advisory vote on executive compensation and approval of the amended and restated Incentive Compensation Plan are on the agenda.
Ratification of Baker Tilly US, LLP as independent auditor for 2026 is proposed.
Shareholder proposals for the 2027 meeting must be submitted by December 31, 2026.
Board of directors and corporate governance
The board consists of four directors, with a lead independent director and separate roles for Executive Chairman and CEO.
All directors attended at least 75% of meetings in 2025, and all attended the 2025 annual meeting.
Three standing committees (Audit, Compensation, Nominating and Corporate Governance) are fully independent except for the Executive Chairman.
The board values diversity, with two African American directors and two committees chaired by African American women.
Latest events from American Shared Hospital Services
- Virtual vote set for June 24, 2026, on directors, pay, incentive plan, and auditor ratification.AMS
Proxy filing30 Apr 2026 - 2025 revenue was $28.1M with a net loss of $1.6M amid a shift to direct patient care.AMS
Q4 202531 Mar 2026 - Q2 2024 net income surged to $3.6M on 27% revenue growth and a major acquisition gain.AMS
Q2 20241 Feb 2026 - Q3 revenue rose 36.3% to $6.99M, but margins fell on higher costs and lower Gamma Knife volumes.AMS
Q3 202414 Jan 2026 - Strong FY 2024 growth led by direct patient services and international expansion.AMS
Q4 202425 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and governance, with focus on diversity.AMS
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification June 26, 2025.AMS
Proxy Filing2 Dec 2025 - Q1 2025 revenue up 17% to $6.1M, led by direct patient services and new centers, but net loss widened.AMS
Q1 202525 Nov 2025 - Q2 2025 revenue up 16% sequentially to $7.1M, but net loss reached $280K.AMS
Q2 202523 Nov 2025